Typical Use
Used from around 10 weeks of pregnancy to estimate the risk of chromosomal abnormalities, including trisomy 21, 18 and 13 and sex chromosome abnormalities. NIPT is a screening test and does not provide a definitive diagnosis.
Preparation
Related tests
APOE Genotype for Alzheimer's Disease (Alleles E2, E3 and E4) [BML]*
APOE Genotype for Alzheimer's Disease (Alleles E2, E3 and E4) [BML] (Stat)*
APOE Genotype for Cardiovascular Diseases (Alleles E2, E3 and E4) [BML]*
Caffeine Sensitivity by CYP1A2*1F Genotyping*
Chromosome Analysis in Blood (N Health)*
DNA Circle Premium*
We use analytics cookies to understand how the site is used. They are only set if you accept, and we never send your test or package details to any analytics service. Privacy Policy